Metabolic & GLP-1
Retatrutide
Triple agonist acting on GIP, GLP-1 and glucagon receptors.
Purity: > 99%Reference: CAS 2381089-83-2
from 115,99 €
Strength / size
115,99 €
Ships within 48 hours
Low stock · 10
For laboratory research use only. Not for human consumption.
Description
Retatrutide is a triple agonist acting on GIP, GLP-1, and glucagon receptors. It has been the subject of clinical research investigating metabolic and body-composition outcomes in research cohorts.
For laboratory research purposes only. Not for human or veterinary use.
Specifications
- 10 mgRETATRUTIDE-10MG
- 115,99 €
Related peptides
★Ships within 2 weeksSemaglutide
> 99%GLP-1 receptor agonist studied for glycemic control and body-weight endpoints.
from 59,99 €
★Ships within 2 weeksTirzepatide
> 99%Dual GIP and GLP-1 receptor agonist studied for metabolic parameters.
from 115,99 €
Ships within 2 weeksAOD-9604
> 99%Modified hGH C-terminal fragment studied for lipolytic pathways.
from 24,99 €